Profile
Michel Cimon worked as VP-Medical Affairs & Director-Medical Affairs at Merck KGaA from 2007 to 2011.
Prior to that, he was Director-Medical & Professional Affairs at GlaxoSmithKline, Inc. from 1996 to 2006.
He also worked as a Director at 4 Touchdowns Capital, Inc. Mr. Cimon's education includes an undergraduate degree from McGill University and an undergraduate degree from the University of Sherbrooke.
He also holds a graduate degree from the University of California.
Former positions of Michel Cimon
| Companies | Position | End |
|---|---|---|
| KLOX TECHNOLOGIES INC | Chief Tech/Sci/R&D Officer | 2018-01-31 |
| MERCK KGAA | Chief Tech/Sci/R&D Officer | 2011-11-30 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 2006-02-28 |
4 Touchdowns Capital, Inc.
 4 Touchdowns Capital, Inc. Financial ConglomeratesFinance 4 Touchdowns Capital, Inc. provides investment services. Its principal business is to identify, evaluate and if warranted, acquire an interest in a business or assets. The company was founded on Febuary26, 2015 is headquartered in Vancouver, Canada. | Director/Board Member | - |
Training of Michel Cimon
| McGill University | Undergraduate Degree |
| University of Sherbrooke | Undergraduate Degree |
| University of California | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MERCK KGAA | Health Technology |
| Private companies | 3 |
|---|---|
KLOX Technologies, Inc.
 KLOX Technologies, Inc. Medical SpecialtiesHealth Technology KLOX Technologies, Inc. designs and develops therapeutic and cosmetic products. The firm offers fluorescence biomodulation technology. The company was founded by Francesco Bellini in 2007 and is headquartered in Laval, Canada. | Health Technology |
4 Touchdowns Capital, Inc.
4 Touchdowns Capital, Inc. Financial ConglomeratesFinance 4 Touchdowns Capital, Inc. provides investment services. Its principal business is to identify, evaluate and if warranted, acquire an interest in a business or assets. The company was founded on Febuary26, 2015 is headquartered in Vancouver, Canada. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Michel Cimon
